2015
DOI: 10.1016/j.jddst.2015.04.007
|View full text |Cite
|
Sign up to set email alerts
|

Enhancement of alendronate encapsulation in chitosan nanoparticles

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

3
34
0

Year Published

2017
2017
2023
2023

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 60 publications
(37 citation statements)
references
References 29 publications
(21 reference statements)
3
34
0
Order By: Relevance
“…The initial burst release from the chitosan nanoparticles is either because of swelling of the polymer, creating pores, or diffusion of the drug from the surface of the polymer [27]. Chitosan nanoparticles also exhibit a pH-dependent drug release because of the solubility of chitosan [28]. Chitosan derivatives alter the release of drug from the NP, affording tunable drug release [29] and impacting the pharmacokinetic profile of the loaded drug.…”
Section: Drug Release From Chitosan Nanoparticlesmentioning
confidence: 99%
See 1 more Smart Citation
“…The initial burst release from the chitosan nanoparticles is either because of swelling of the polymer, creating pores, or diffusion of the drug from the surface of the polymer [27]. Chitosan nanoparticles also exhibit a pH-dependent drug release because of the solubility of chitosan [28]. Chitosan derivatives alter the release of drug from the NP, affording tunable drug release [29] and impacting the pharmacokinetic profile of the loaded drug.…”
Section: Drug Release From Chitosan Nanoparticlesmentioning
confidence: 99%
“…High NP encapsulation efficiency of alendronate sodium was achieved by formulating chitosan nanoparticles via an ion gelation technique. Drug release was clearly pH-dependent; in 0.1N HCl, almost 80% of the drug was released within 60 min while in PBS (pH 6.8) a maximum of 40% of the drug was released over 4 h, suggesting that factors other than chitosan’s pH solubility profile influenced drug release in this case and that optimization is multifactorial [28]. This highlights the importance of examining the degree of surface coverage of the nanoparticles with chitosan and of performing ongoing dissolution studies in biorelevant media during formulation development.…”
Section: Chitosan In Oral Drug Deliverymentioning
confidence: 99%
“…Furthermore, the pH dependent solubility of chitosan enables tuneable pH-dependent release [9], which can be further tailored by derivatisation [10] or cross-linking (with TPP for example)…”
Section: Introductionmentioning
confidence: 99%
“…Several drugs and polyphenolsencapsulated inside chitosan moieties were synthesized such as catechin and epigallocatechin [16], tamoxifen [17], alendronate sodium [18], insulin [19] and peptide [20]. These nanoparticles are delivered in severalapproachesincluding injection drug delivery [21], topical drug delivery [22], colon-targeted drug delivery [23], carcinoma therapy [24] and gene delivery [25].…”
Section: Chitosan In Nanosciencementioning
confidence: 99%